However, enterolactone urinary levels were associated with reduced obesity, reduced C-reactive protein, reduced blood pressure, reduced triglycerides, higher serum–HDL-cholesterol, and a lower occurrence of metabolic syndrome. The gene discussed is CRP; the disease is obesity disorder.